Convertible bond issue for GENFIT
Natixis recently led a €180m convertible bond issue for GENFIT, which develops therapeutic solutions in metabolic and inflammatory diseases that notably affect the liver. This issue is the largest for a biopharmaceutical company in Europe and the first issue in France.
Natixis leads Vallourec’s OCEANE issue
Vallourec has mandated Natixis to conduct* its 2022 €250m OCEANE convertible bond issue**.
This is the first bond issue of the world leader in premium tubular solutions Vallourec since 2014. Net proceeds from the issue will be used for the company’s general corporate purposes.
N°1 of European Real Estate
Natixis ranks No. 1 Bookrunner and N°1 MLA for real estate finance in EMEA for the first half 2017, according to Dealogic.